Three-Dimensional Matrix-Induced Autologous Chondrocytes Implantation for Osteochondral Lesions of the Talus: Midterm Results

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Score</td><td align="center">Preop. average ± sd</td><td align="center">Follow-up average ± sd</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">AOFAS (0–100)</td><td align="center">36,9 ± 6,6</td><td align="center">83,9 ± 13,6</td></tr><tr><td align="left">VAS (0–190)</td><td align="center"></td><td align="center">141,1 ± 35,6</td></tr><tr><td align="left">COUGHLIN (1–4)</td><td align="center"></td><td align="center">3,1 ± 0,8</td></tr><tr><td align="left">MOCART (0–7)</td><td align="center">6,3 ± 0,8</td><td align="center">3,8 ± 0,9</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

AOFAS, VAS, Coughlin, and MOCART scores’ mean values before surgery and at follow-up. 

Advances in Orthopedics

tab2

Table 2

Table 2: Three-Dimensional Matrix-Induced Autologous Chondrocytes Implantation for Osteochondral Lesions of the Talus: Midterm Results 